{
  "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4",
  "docSlug": "e307aa667077aaa87591999f61390379",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 28,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "Uses data from Ladabaum U, et al. (JNCI, 2022) to justify the importance of AA detection thresholds.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/12",
  "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4",
  "deckJsonHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4.json",
  "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.87,
        "x": 0.052,
        "y": 0.00155
      },
      "kind": "callout",
      "text": "Including AAs detection in screening tests significantly reduces both incidence and mortality",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06d61d5e-f483-4cb9-b010-593d3c4149ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.052,
        "y": 0.0038
      },
      "kind": "list",
      "text": "If a screening tests in 45yr olds and above resulted in:",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e699f2e-362d-4261-8495-d67cabc2de7f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.32,
        "x": 0.12,
        "y": 0.004200000000000001
      },
      "kind": "metric",
      "text": "21% sensitivity for AA: Reduction of CRC incidence by 30% Reduction of CRC mortality by 47%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "166c406b-fd39-4c0b-808e-ce6cbe261cf6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.32,
        "x": 0.12,
        "y": 0.0060999999999999995
      },
      "kind": "metric",
      "text": "76% sensitivity for AA: Reduction in CRC incidence by 57% Reduction in CRC mortality by 67%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "741b36d2-0322-45ee-b31d-f978691719ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.052,
        "y": 0.0024
      },
      "kind": "paragraph",
      "text": "Discussion of CMS decision memo on thresholds of 74% sensitivity, 90% specificity for blood-based screening for CRC. No thresholds set for detection of AA.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b13bd3e5-e5c6-4b2a-8983-e59fa617771f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.0081
      },
      "kind": "source-note",
      "text": "Ladabaum U, et al. Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity, JNCI: Journal of the National Cancer Institute, Volume 114, Issue 7, July 2022, Pages 1040-1043",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3fe6cb6-b2be-42ef-b66a-8f5de5830b76",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.798,
        "x": 0.048,
        "y": 0.035
      },
      "kind": "title",
      "text": "Impact of AA sensitivity on CRC Mortality and Incidents Rates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08ecd15f-833c-4e4c-a488-d0687dca6863",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "ea027422-ede2-462e-b3d2-b94007184a5b",
      "evidence": "Presents quantitative clinical outcomes linked to specific sensitivity thresholds.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 12,
      "beatId": "1ce71ae4-d0a5-4023-8530-39586803c466",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document agitates the problem by highlighting the benefits of including AAs detection in screening tests.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "813b4496-b0d9-426f-8ed7-1a465f56b317",
      "evidence": "The document highlights the benefits of early detection and the limitations of current screening tests.",
      "position": 0,
      "objective": "What is the cost of not adopting a more effective CRC screening test?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 13,
      "from": 12,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "f13724b7-816b-4b6a-a8eb-99b7a7b505ba",
      "evidence": "The document presents the benefits of including AAs detection in screening tests and the potential for Mainz Biomed's test.",
      "position": 1,
      "objective": "Why is now the right time for Mainz Biomed's next-generation CRC screening test?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}